Postmarketing safety surveillance for GSK's AS01(E)-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study
美国葛兰素史克AS01(E)佐剂呼吸道合胞病毒融合前F蛋白疫苗上市后安全性监测：一项非干预性上市后安全性研究方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2026-117236
Adimadhyam, Sruthi; Luyts, Dominique; Oraichi, Driss; Deraedt, Quentin; Pircon, Jean-Yves; Bilker, Warren B; Agan, Anna A; Rajbhandari, Rajani; Carbonari, Dean M; Djibo, Djeneba Audrey; Wang, Xi; Nolan, Margaret B; DeVries, Andrea; Selvan, Mano; Ma, Qianli; Wentz, Anna E; Daniels, Kimberly; Platt, Richard; Lo Re, Vincent 3rd; Cocoros, Noelle M
